- Home
- AMC vs CNTA Comparison
AMC vs CNTA Comparison
Compare AMC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMC
- CNTA
- Stock Information
- Founded
- AMC 1920
- CNTA 2020
- Country
- AMC United States
- CNTA United Kingdom
- Employees
- AMC N/A
- CNTA N/A
- Industry
- AMC Movies/Entertainment
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- AMC Consumer Discretionary
- CNTA Health Care
- Exchange
- AMC Nasdaq
- CNTA Nasdaq
- Market Cap
- AMC 1.5B
- CNTA 1.6B
- IPO Year
- AMC 2013
- CNTA 2021
- Fundamental
- Price
- AMC $2.82
- CNTA $13.17
- Analyst Decision
- AMC Hold
- CNTA Strong Buy
- Analyst Count
- AMC 7
- CNTA 10
- Target Price
- AMC $3.92
- CNTA $28.78
- AVG Volume (30 Days)
- AMC 8.6M
- CNTA 1.2M
- Earning Date
- AMC 08-01-2025
- CNTA 08-12-2025
- Dividend Yield
- AMC N/A
- CNTA N/A
- EPS Growth
- AMC N/A
- CNTA N/A
- EPS
- AMC N/A
- CNTA N/A
- Revenue
- AMC $4,548,300,000.00
- CNTA $15,000,000.00
- Revenue This Year
- AMC $8.36
- CNTA N/A
- Revenue Next Year
- AMC $6.63
- CNTA N/A
- P/E Ratio
- AMC N/A
- CNTA N/A
- Revenue Growth
- AMC N/A
- CNTA 118.88
- 52 Week Low
- AMC $2.45
- CNTA $8.46
- 52 Week High
- AMC $5.76
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- AMC 36.88
- CNTA 53.38
- Support Level
- AMC $2.95
- CNTA $12.74
- Resistance Level
- AMC $3.14
- CNTA $14.27
- Average True Range (ATR)
- AMC 0.11
- CNTA 0.71
- MACD
- AMC -0.04
- CNTA 0.08
- Stochastic Oscillator
- AMC 4.24
- CNTA 56.11
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.